共 116 条
[1]
Baigent C(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-1278
[2]
Keech A(2008)Statins inhibit proliferation and induce apoptosis in Barrett’s esophageal adenocarcinoma cells Am J Gastroenterol 103 825-837
[3]
Kearney PM(2011)Barrett’s esophagus: progression to adenocarcinoma and markers Ann N Y Acad Sci 1232 210-229
[4]
Ogunwobi OO(2013)Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study Dis Esophagus 26 838-846
[5]
Beales IL(2014)Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis Gastroenterology 146 661-668
[6]
Fang D(2013)Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis[J] Clin Gastroenterol Hepatol 11 620-629
[7]
Das KM(2013)Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study Dis Esophagus 26 838-846
[8]
Cao W(2011)Statin therapy attenuates growth and malignant potential of human esophageal adenocarcinoma cells J Thorac Cardiovasc Surg 142 1152-1160
[9]
Malhotra U(2011)Oesophageal cancer–an aetiological investigation into the potential protective effect of statins in the UK general practice research database (GPRD) Gastroenterology 140 S-166
[10]
Triadafilopoulos G(2006)Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies Biomed Chromatogr 20 282-293